Skip to main content
editorial
. 2021 Jul 2;10(4):289–295. doi: 10.1159/000517841

Fig. 2.

Fig. 2

Immune surveillance and antitumor response are impaired/lacking in CD8+ T cells (CXCR6+CD8+ T cell) in mouse models of NAFLD/NASH and NAFLD/NASH-related HCC. NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; HCC, hepatocellular carcinoma.